Intrinsic Value
Monte Rosa Therapeutics, Inc. (GLUE)
$5.5
-0.35 (-5.98%)
| Enterprise Value | - |
|---|---|
| Net Debt | -82.06 |
| Equity Value | - |
| Shares Outstanding | 51.40 |
| Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt